THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
IMI 9TH CALL FOR PROPOSALS
Topics under consideration for IMI's 9th Call for proposals are:
- Leveraging technologies for pharmacovigilance
- Physical frailty and sarcopenia
- Developing drug-drug combinations
- Antimicrobial resistance (two topics)
ONGOING PROJECTS
Action on autism
EU-AIMS is developing tools that will help us to boost our understanding of autism spectrum disorders, paving the way for new treatments
... moreDiabetes treatment gets personal
DIRECT is identifying different subtypes of type 2 diabetes to determine the most appropriate treatments for them
... moreGet on-course!
EMTRAIN officially launches on-course - with over 4 200 courses, it's Europe's most comprehensive biomedical R&D postgrad course portal
... moreInnovation in action
IMI supports 40 projects with a combined budget of €1.2 billion covering drug safety & efficacy, knowledge management, and education &... more
Liver-friendly drugs
MIP-DILI is developing tests to help detect liver toxicity problems early in development, saving many patients from the trauma of liver failure
... morePatient power!
EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process
... moreTaking on TB
PreDiCT-TB is speeding up the search for new, more effective combinations of treatments to tackle the deadly disease tuberculosis (TB)
... moreTowards safer drugs
ABIRISK is boosting the safety of biopharmaceuticals, novel drugs that have already proven effective at treating certain serious conditions.
... moreVaccine safety
BIOVACSAFE is developing cutting edge tools to speed up and improve the testing and monitoring of vaccine safety
... more
SIGN UP FOR IMI'S INFO SESSION IN BARCELONA
Registration is open for IMI's info session on 28 June in Barcelona, Spain.
- IMI's rules and procedures
- Tips on preparing a successful proposal
- Overview of Call topics
IMI NEWSFLASH 
- 19/06/2013 : RT @EFPIA: Learn more about the Innovative Medicines Initiative on the EFPIA website @IMI_JU #innovation - http://t.co/pZ0Hfu2Jy1
- 19/06/2013 : RT @DDMoRe_IMI: At PAGE, Nick Holford and Mike K Smith presented: MDL - The DDMoRe modelling description language, also available at http:/…
- 18/06/2013 : RT @eTRIKS1: A sad truth about all the translational research data that is being collected. http://t.co/J2jFxHy0Gk
Innovative Medicines Initiative 2010